Pamplona Capital Management Nears Deal to Buy Parexel

Ivan Schwartz
June 20, 2017

The acquisition is expected to close in the fourth quarter.

PAREXEL International Corporation (NASDAQ:PRXL)'s EPS growth this year is 8.00% and the trailing 12-month EPS is $2.27.

The share price has moved forward from its 200 days moving average, trading at a distance of 25.29% and stays 14.47% away from its 50 days moving average. The stock's market capitalization is 4.26B. PAREXEL International Corporation has a 1-year low of $51.16 and a 1-year high of $84.06. This SMA data will help a long-term trader to figure out that PAREXEL International Corporation (NASDAQ:PRXL) stock price level can be now recognized as a major support and therefore the stock is an overall uptrend, as a stock's price remains above the 200 SMA on the daily time frame.

-Reuters contributed to this reporting. PAREXEL International Corporation had a net margin of 5.12% and a return on equity of 28.68%. MA boosted its position in PAREXEL International Corporation by 6.9% in the first quarter. In the latest earnings report the EPS was $2.28 and is projected to be $3.24 for the current year with 50,762,000 shares now outstanding. If you are reading this report on another website, it was copied illegally and republished in violation of USA & worldwide copyright & trademark legislation. The correct version of this article can be accessed at [[permalink]].

Kvitova wins opening match on grass in Birmingham
We have still been worrying about it (the injury) so I still have days off, to remind us to be careful". She played in the French Open last month and won her first match but lost her second.

Bill Cosby's team attacks judge likely to retry sex case
Camille Cosby, 73, only attended one day of the trial with her husband. "I'm sorry it's causing everyone frustration". Cosby, 79, is accused of drugging and molesting a Temple University employee in 2004 at his home near Philadelphia.

Emotional Adam Braidwood offers condolences to Tim Hague's family in video statement
Instead of leaving a comment, contact his family. "Help them in any way that you can and let's try to leave it at that". A family member of Hague's has started a GoFundMe campaign to help raise money for funeral expenses.

Here are a few additional firms who have increased or decreased their stake in (PRXL). Finally, Barclays PLC reiterated an "overweight" rating and issued a $87.00 target price on shares of PAREXEL International Corporation in a research report on Wednesday, May 17th.

05/15/2017 - PAREXEL International Corporation was upgraded to "outperform" by analysts at Evercore ISI. On May 23 the stock rating was upgraded from " to "Neutral" in an announcement from Goldman Sachs. Credit Suisse Group reiterated a "neutral" rating and set a $83.00 price objective (up from $65.00) on shares of PAREXEL International Corporation in a research note on Tuesday, June 6th. Covering sell-side analysts are estimating company growth for next year to be 19.13%. The stock has a consensus rating of "Hold" and an average target price of $72.83.

Parexel International, a global biopharmaceutical services provider, will be acquired by Pamplona Capital Management, the two companies announced Tuesday.

Parexel International Corp., based in Waltham, Massachusetts, provides clinical research, technology consulting and medical communications to the drug and medical device industries.

Other reports by GizPress

Discuss This Article